...
首页> 外文期刊>Journal of clinical psychopharmacology >Topiramate for the treatment of polydipsia-hyponatremia syndrome.
【24h】

Topiramate for the treatment of polydipsia-hyponatremia syndrome.

机译:托吡酯治疗多饮性低钠血症综合征。

获取原文
获取原文并翻译 | 示例
           

摘要

Because Patient A had chronic poly-dipsia and had no history of bipolar disorder, and no change in his schizophrenia symptoms was noted over the course of his treatment, topiramate was felt to be a salient factor in his improvement. The threshold effect noted in his response suggests that the effect of topiramate is not linear and that a minimum dose may be required to achieve efficacy. The efficacy of topiramate in this individual may be related to activity at AMPA/kainate receptors in the hypothalamus because they are implicated in the regulation of feeding behaviors.16'17 Alternately, Patient A's poly-dipsia may represent a form of addictive or compulsive behavior.
机译:由于患者A有慢性多饮症且没有躁郁症病史,并且在治疗过程中未发现精神分裂症症状发生任何变化,因此托吡酯被认为是病情改善的重要因素。他的反应中指出的阈值效应表明托吡酯的效应不是线性的,可能需要最小剂量才能达到疗效。托吡酯在该个体中的功效可能与下丘脑中AMPA /海藻酸酯受体的活性有关,因为它们与进食行为的调节有关。16'17或者,患者A的多饮性可能表示成瘾或强迫行为的一种形式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号